James E. Bates, MD on Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma @JamesBatesMD @UF

James E. Bates, MD on Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma @JamesBatesMD @UF

Cancer-News

2 months
14 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Dr. James Bates, MD @JamesBatesMD of University of Florida @UF discusses long term outcomes in 10-year survivors of early-stage hodgkin lymphoma.

________

Although radiation therapy enhances progression-free survival in early-stage Hodgkin lymphoma (HL), significant questions remain about the effect on quality of life and survival of delayed normal tissue impacts. We hypothesized that combined-modality therapy (CMT; chemotherapy and radiation therapy) care increases overall survival among 10-year survivors as opposed to radiation therapy or chemotherapy care alone.

Up Next Autoplay